| CTRI Number |
CTRI/2024/11/076702 [Registered on: 12/11/2024] Trial Registered Prospectively |
| Last Modified On: |
01/08/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Observational |
| Study Design |
Other |
|
Public Title of Study
|
Effectiveness of new contrast sensitivity chart in measuring contrast functions among clinical population |
|
Scientific Title of Study
|
Effectiveness of novel contrast sensitivity chart as compared to standard Pelli Robson chart in measuring contrast sensitivity in clinical practice |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Namratha H |
| Designation |
Associate Proffessor |
| Affiliation |
Sankara College of Optometry |
| Address |
Department of Optometry, Sankara College of Optometry, Sankara Eye HOspital , Varthur Main Road , Kundalahalli Gate , Banglore
Bangalore KARNATAKA 560037 India |
| Phone |
9986266576 |
| Fax |
|
| Email |
namratha.hedge@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Namratha H |
| Designation |
Associate Proffessor |
| Affiliation |
Sankara College of Optometry |
| Address |
Department of Optometry, Sankara College of Optometry, Sankara Eye HOspital , Varthur Main Road , Kundalahalli Gate , Banglore
Bangalore KARNATAKA 560037 India |
| Phone |
9986266576 |
| Fax |
|
| Email |
namratha.hedge@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Namratha H |
| Designation |
Associate Proffessor |
| Affiliation |
Sankara College of Optometry |
| Address |
Department of Optometry, Sankara College of Optometry, Sankara Eye HOspital , Varthur Main Road , Kundalahalli Gate , Banglore
Bangalore KARNATAKA 560037 India |
| Phone |
9986266576 |
| Fax |
|
| Email |
namratha.hedge@gmail.com |
|
|
Source of Monetary or Material Support
|
| Sankara Eye Hospital, Varthur Main Road, Kunadalahalli Signal, Bengaluru |
|
|
Primary Sponsor
|
| Name |
Sankara Eye Hospital |
| Address |
Sankara Eye Hospital ,Varthur main road, Kundalahalli signal,Banglore |
| Type of Sponsor |
Private hospital/clinic |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Namratha |
Sankara Eye Hospital |
Sankara Eye Hospital,Varthur main road, Kundahalli Gate, Banglore
560037 Bangalore KARNATAKA |
9986266576
namratha.hedge@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Sankara Eye Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: H251||Age-related nuclear cataract, (2) ICD-10 Condition: H401||Open-angle glaucoma, (3) ICD-10 Condition: H402||Primary angle-closure glaucoma, (4) ICD-10 Condition: H36||Retinal disorders in diseases classified elsewhere, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Pelli Robson chart |
Contrast sensitivity measured with novel chart is being compared to standard Pelli Robson contrast sensitivity chart |
|
|
Inclusion Criteria
|
| Age From |
35.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
K/C/O POAG,PACG,OHT,NTG( classification based on ISGEO )
Cataract
Retinal related diseases |
|
| ExclusionCriteria |
| Details |
Amblyopia
Pseudophakia
Corneal conditions
Secondary glaucoma
Juvenile glaucoma
Neurological conditions
Drug toxicity
|
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Other |
|
Blinding/Masking
|
Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To check for the effectivness of novel contrast senstivity as comapred to standard pelli robson chart among clinical population |
One visit |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To compare the values measured with Novel Contrast Sensitivity Chart to Standard Pelli-Robson chart among clinical population |
one visit |
|
|
Target Sample Size
|
Total Sample Size="176" Sample Size from India="176"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
28/11/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
An Observation study to check the effectiveness of Novel Contrast Sensitivity Chart as compared to standard Pelli-Robson chart in measuring contrast sensitivity in clinical practice, with the inclusion criteria of K/C/O POAG,PACG ,OHT and NTG(classification based on ISGEO) , cataract and retinal related conditions: Exclusion criteria of Amblyopia, pseudophakia, corneal related conditions, secondary glaucoma, juvenile glaucoma and drug toxicity. This novel chart has been created such that, it gives the contrast sensitivity at each level of visual acuity from 1.00logMAR to 0.00logMAR unlike the standard Pelli Robson CS chart with fixed letter size all throughout the chart. This novel chart may help us in identifying the subtle progression in condition among the clincial population. Hence the study aims to check the effectiveness of Novel Contrast Sensitivity Chart as compared to standard Pelli-Robson chart in measuring contrast sensitivity in clinical practice. |